139 related articles for article (PubMed ID: 37417609)
1. Prognostic value of sarcopenic visceral obesity in hepatocellular carcinoma treated with TACE.
Li Y; Hou J; Chen R
Medicine (Baltimore); 2023 Jul; 102(27):e34292. PubMed ID: 37417609
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.
Iritani S; Imai K; Takai K; Hanai T; Ideta T; Miyazaki T; Suetsugu A; Shiraki M; Shimizu M; Moriwaki H
J Gastroenterol; 2015 Mar; 50(3):323-32. PubMed ID: 24817668
[TBL] [Abstract][Full Text] [Related]
3. The role of muscle depletion and visceral adiposity in HCC patients aged 65 and over undergoing TACE.
Lim J; Kim KW; Ko Y; Jang IY; Lee YS; Chung YH; Lee HC; Lim YS; Kim KM; Shim JH; Choi J; Lee D
BMC Cancer; 2021 Oct; 21(1):1164. PubMed ID: 34715813
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
Fujiwara N; Nakagawa H; Kudo Y; Tateishi R; Taguri M; Watadani T; Nakagomi R; Kondo M; Nakatsuka T; Minami T; Sato M; Uchino K; Enooku K; Kondo Y; Asaoka Y; Tanaka Y; Ohtomo K; Shiina S; Koike K
J Hepatol; 2015 Jul; 63(1):131-40. PubMed ID: 25724366
[TBL] [Abstract][Full Text] [Related]
5. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
[TBL] [Abstract][Full Text] [Related]
6. Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.
Kobayashi A; Kaido T; Hamaguchi Y; Okumura S; Shirai H; Yao S; Kamo N; Yagi S; Taura K; Okajima H; Uemoto S
Ann Surg; 2019 May; 269(5):924-931. PubMed ID: 29064889
[TBL] [Abstract][Full Text] [Related]
7. High visceral fat attenuation and long-term mortality in a health check-up population.
Lee JH; Choi SH; Jung KJ; Goo JM; Yoon SH
J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1495-1507. PubMed ID: 37016984
[TBL] [Abstract][Full Text] [Related]
8. Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection.
Yabusaki N; Fujii T; Yamada S; Suzuki K; Sugimoto H; Kanda M; Nakayama G; Koike M; Fujiwara M; Kodera Y
Int J Surg; 2016 Jun; 30():136-42. PubMed ID: 27154615
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
Chen BB; Liang PC; Shih TT; Liu TH; Shen YC; Lu LC; Lin ZZ; Hsu C; Hsu CH; Cheng AL; Shao YY
Eur Radiol; 2023 Jan; 33(1):512-522. PubMed ID: 35864351
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenic visceral obesity is associated with increased post-liver transplant mortality in acutely ill patients with cirrhosis.
Ha NB; Montano-Loza AJ; Carey EJ; Lin S; Shui AM; Huang CY; Dunn MA; Lai JC
Am J Transplant; 2022 Sep; 22(9):2195-2202. PubMed ID: 35486028
[TBL] [Abstract][Full Text] [Related]
11. Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.
Kamo N; Kaido T; Hamaguchi Y; Okumura S; Kobayashi A; Shirai H; Yao S; Yagi S; Uemoto S
Clin Nutr; 2019 Oct; 38(5):2202-2209. PubMed ID: 30482562
[TBL] [Abstract][Full Text] [Related]
12. The predictive value of sarcopenia and myosteatosis in trans-arterial (chemo)-embolization treated HCC patients.
Long J; Zhang X; Mi W; Shi J; Ren H; Wang Q
Aging (Albany NY); 2024 Jan; 16(1):389-401. PubMed ID: 38189812
[TBL] [Abstract][Full Text] [Related]
13. The Prevalence Rate of Adult Sarcopenic Obesity and Correlation of Appendicular Skeletal Muscle Mass Index with Body Mass Index, Percent Body Fat, Waist-Hip Ratio, Basal Metabolic Rate, and Visceral Fat Area.
Luo X; Cai B; Jin W
Metab Syndr Relat Disord; 2023 Feb; 21(1):48-56. PubMed ID: 36318808
[No Abstract] [Full Text] [Related]
14. Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.
Lanza E; Masetti C; Messana G; Muglia R; Pugliese N; Ceriani R; Lleo de Nalda A; Rimassa L; Torzilli G; Poretti D; D'Antuono F; Politi LS; Pedicini V; Aghemo A;
PLoS One; 2020; 15(6):e0232371. PubMed ID: 32555707
[TBL] [Abstract][Full Text] [Related]
15. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study.
Fukuda T; Bouchi R; Takeuchi T; Tsujimoto K; Minami I; Yoshimoto T; Ogawa Y
Cardiovasc Diabetol; 2018 Apr; 17(1):55. PubMed ID: 29636045
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed Hepatocellular Carcinoma, Independent of Tumor Stage and Liver Function.
Ha Y; Kim D; Han S; Chon YE; Lee YB; Kim MN; Lee JH; Park H; Rim KS; Hwang SG
Cancer Res Treat; 2018 Jul; 50(3):843-851. PubMed ID: 28882021
[TBL] [Abstract][Full Text] [Related]
17. Detection of sarcopenic obesity and prediction of long-term survival in patients with gastric cancer using preoperative computed tomography and machine learning.
Kim J; Han SH; Kim HI
J Surg Oncol; 2021 Dec; 124(8):1347-1355. PubMed ID: 34490899
[TBL] [Abstract][Full Text] [Related]
18. Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies.
Loosen SH; Jördens MS; Schoon B; Antoch G; Luedde T; Minko P; Loberg C; Roderburg C
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6181-6190. PubMed ID: 36689060
[TBL] [Abstract][Full Text] [Related]
19. Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody.
Akce M; Liu Y; Zakka K; Martini DJ; Draper A; Alese OB; Shaib WL; Wu C; Wedd JP; Sellers MT; Bilen MA; El-Rayes BF
Am J Clin Oncol; 2021 Feb; 44(2):74-81. PubMed ID: 33350681
[TBL] [Abstract][Full Text] [Related]
20. Association of myosteatosis with treatment response and survival in patients with hepatocellular carcinoma undergoing chemoembolization: a retrospective cohort study.
Bannangkoon K; Hongsakul K; Tubtawee T; Ina N; Chichareon P
Sci Rep; 2023 Mar; 13(1):3978. PubMed ID: 36894658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
